Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Wiener Klinische Wochenschrift

• Publication date

  1999-02-12

• Fields of study

  Medicine

• Identifiers
  PMID 10093893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.

  1998cited by this paper
• Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.

  1997cited by this paper
• The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets.

  1997cited by this paper
• Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphatics.

  1997cited by this paper
• In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

  1997cited by this paper
• Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

  1997cited by this paper
• Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions.

  1997cited by this paper
• [Isoprostanes, a new substance group in angiology--of future significance?].

  1997cited by this paper
• Local Amplification of Platelet Function by 8-Epi Prostaglandin F2α Is Not Mediated by Thromboxane Receptor Isoforms*

  1996cited by this paper
• The isoprostanes. Current knowledge and directions for future research.

  1996cited by this paper
• Intracellular signaling by 8-epi-prostaglandin F2 alpha is mediated by thromboxane A2/prostaglandin endoperoxide receptors in porcine carotid arteries.

  1996cited by this paper
• [Single passive smoking exposure induces no measurable oxidation of low density lipoproteins].

  1996cited by this paper
• Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.

  1996cited by this paper
• Coronary artery constriction by the isoprostane 8‐epi prostaglandin F2α

  1996cited by this paper
• Modulation of oxidant stress in vivo in chronic cigarette smokers.

  1996cited by this paper
• Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

  1995cited by this paper
• Effects of the isoprostane, 8-epi-prostaglandin F2 alpha, on the contractility of the human myometrium in vitro.

  1995cited by this paper
• Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.

  1995cited by this paper
• [1995 consensus guidelines for cholesterol. Society of Physicians in Vienna].

  1995cited by this paper
• The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients.

  1994cited by this paper
• Cyclooxygenase‐Dependent Formation of the Isoprostane 8‐EPI Prostaglandin F2α a

  1994cited by this paper
• Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.

  1994cited by this paper
• Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes.

  1994cited by this paper
• Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.

  1994cited by this paper
• Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.

  1994cited by this paper
• Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma.

  1993cited by this paper
• The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

  1992cited by this paper
• The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist.

  1992cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper

• Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2)

  2019cites this paper
• One year follow-up of patients with reduced left ventricular ejection fraction (LVEF) on lipoprotein apheresis.

  2019cites this paper
• Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries

  2017cites this paper
• Institute of Experimental and Clinical Pharmacology and Toxicology Clinical Pharmacology

  2007cites this paper
• Isoprostanes and Phospholipases, Markers and Mediators of Oxidative Stress

  2007cites this paper
• Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.

  2007cites this paper
• Markers and Mediators of Oxidative Stress

  2007cites this paper
• Zinc as antiperoxidative agent following iodine-131 induced changes on the antioxidant system and the morphology of red blood cells.

  2007cites this paper
• Passive cigarette smoking increases isoprostane formation.

  2006cites this paper
• Elevated urinary 8-isoprostaglandin F(2alpha) in females with Graves' hyperthyroidism.

  2004cites this paper
• Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems.

  2004cites this paper
• Elevated urinary 8-isoprostaglandin F2α in females with Graves’ hyperthyroidism

  2004cites this paper
• Urinary 8-isoprostoglandin F-2 alpha: a new marker in hyperthyroidism?

  2004cites this paper
• Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein.

  2004cites this paper
• Application of Gas Chromatography-Mass Spectrometry for Analysis of Isoprostanes: Their Role in Cardiovascular Disease

  2003cites this paper
• The contractile response of the mesenteric resistance arteries to prostaglandin F2α; effects of simultaneous hyperlipemia–diabetes

  2003cites this paper
• Increased isoprostanes in children of smoking parents.

  2003cites this paper
• Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research

  2003cites this paper
• Vasodilatory and Electrophysiological Actions of 8-iso-Prostaglandin E2 in Porcine Coronary Artery

  2003cites this paper
• Muscular Side Effects of Statins

  2002cites this paper
• Flu-like response on statins.

  2002cites this paper
• Oxidation Injury in Patients Receiving HMG-CoA Reductase Inhibitors

  2002cites this paper
• Radioiodine therapy induces dose-dependent in vivo oxidation injury: evidence by increased isoprostane 8-epi-PGF(2 alpha).

  2002cites this paper
• Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis.

  2002cites this paper
• Enhanced accumulation of the isoprostane, 8-epi-PGF2 alpha, in human aortic and pulmonary valves of patients with coronary heart disease.

  2002cites this paper
• Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men

  2001cites this paper
• Isoprostane 8‐epi‐PGF2α is frequently increased in patients with muscle pain and/or CK‐elevation after HMG‐Co‐enzyme‐A‐reductase inhibitor therapy

  2001cites this paper
• Regular ingestion of opuntia robusta lowers oxidation injury

  2001cites this paper
• Regular ingestion of opuntia robusta lowers oxidation injury.

  2001cites this paper
• Prostaglandins and lipid modification.

  2001cites this paper
• Increased Isoprostane 8-epi-PGF2A in Statin-Induced Myopathy

  2001cites this paper
• Increase of isoprostane 8-epi-PGF2 αafter restarting smoking

  2001cites this paper
• Increase of isoprostane 8-epi-PGF(2alpha)after restarting smoking.

  2001cites this paper
• Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokers.

  2000cites this paper
• Isoprostanes in atherosclerosis.

  2000cites this paper
• Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane).

  2000cites this paper
• Increased lipid peroxidation in a patient with CK-elevation and muscle pain during statin therapy.

  2000cites this paper
• Distinct effects of LDL apheresis by hemoperfusion (DALI) and heparin‐induced extracorporeal precipitation (HELP) on leukocyte respiratory burst activity of patients with familial hypercholesterolemia

  2000cites this paper
• Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia.

  1999cites this paper